<scp>ADAM</scp> 8 expression in invasive breast cancer promotes tumor dissemination and metastasis
2013 · EMBO Molecular Medicine · 103 citations
https://doi.org/10.1002/emmm.201303373
S
Srimathi Srinivasan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
96
Papers
641
Citations
11
h-index
11
i10-index
Srimathi Srinivasan is an academic researcher from Johnson & Johnson (United States). The author has contributed to research in topics: Immune cells in cancer & Mast cells and histamine & Synthesis and Catalytic Reactions. The author has an h-index of 11, co-authored 82 publications.
ORCID: 0000-0001-7202-9425Papers by this author
worksHypoxia-induced expression of phosducin-like 3 regulates expression of VEGFR-2 and promotes angiogenesis
2015 · Angiogenesis · 59 citations
https://doi.org/10.1007/s10456-015-9468-3
Evaluation of Bruton’s Tyrosine Kinase (BTK) inhibition with alternative doses of ibrutinib in subjects with Chronic Lymphocytic Leukemia (CLL)
2025 · Cancer Chemotherapy and Pharmacology · 6 citations
https://doi.org/10.1007/s00280-025-04753-0
Supplementary Figure 4 from Novel arginase inhibitor, AZD0011, demonstrates immune cell stimulation and anti-tumor efficacy with diverse combination partners
2024 · 0 citations
https://doi.org/10.1158/1535-7163.27035725
Supplementary Figure 2 from Novel arginase inhibitor, AZD0011, demonstrates immune cell stimulation and anti-tumor efficacy with diverse combination partners
2024 · 0 citations
https://doi.org/10.1158/1535-7163.27035731
Supplementary Figure 5 from Novel arginase inhibitor, AZD0011, demonstrates immune cell stimulation and anti-tumor efficacy with diverse combination partners
2024 · 0 citations
https://doi.org/10.1158/1535-7163.27035722
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat